1. Role of Ministry of Health and Medical Education in management and control of Hepatitis C
2016/07/13

2. History of MOHME interventions-1
From 1992 HBV vaccination at birthday began in the country and till now it covers more than 99% of newborns each year about one and a half million neonates .
Additionally 4 age cohorts (people born at 1988 to 1991) vaccinated , the result : All Iranian and long term residents below 29 years old are vaccinated against hepatitis B .

3. MOHME interventions -2
From the 1990s the Harm reduction efforts for HIV epidemics in the country especially in IDUs has resuled in diminishing HCV transmission .
Also insuring Peg-Interferon and Ribavirin in and their availability for nearly all people , and their effect in HCV elimination in30 % of treated patients ,Both resulted in diminishing HCV transmission.

4. Incidence rate of HBV&HCV , from 2003 to 2015

5. Hepatitis C elimination program
MOHME
CCDC

6. Hepatitis C elimination program
Viral hepatitis , besides AIDS and TB are important causes in morbidity and mortality due to communicable diseases globally.
Elimination of epidemics of HCV until 2030 is one of the WHO goals .

7. Viral Hepatitis
90% of chronic hepatitis patients are not aware of their diseases .
Each year there are 6-10 million new cases.
With new drugs 90% of HCV patients cure after 3 months treatment .
Number of global chronic hepatitis B&C are more than 10 times of HIV infections . .

8. Viral Hepatitis Each year 1.4 million mortality due to viral hepatitis
Now there are effective drugs for treating HCV and effective vaccine for HBV
HCV elimination as a major
health problem .

9. Hepatitis C elimination program
Availability of HCV lab tests from 1st(serology) to 3rd levels( molecular tests).
Serology of HCV available in the periphery
Creation of diagnostic and treatment algorithms for peripheral levels .
Specifying routs of referral for sever and complicated cases from 1st to 3rd level .

10. Hepatitis C elimination program
Continuing neonates HBV vaccination .
Vaccination of 4 more age cohorts in 4 years for coming to HBV vaccination coverage up to 35 years old Iranians .
Vaccination of all prisoners(has begun)
Vaccination of high risk employees like municipal workers, cemetery workers- barbers – firefighters and blood donors (has begun) .

11. HBV elimination program
High risk groups vaccination through DICs-VCTs and MMTs .
Continuing HCWs , HBV vaccination .

12. HBV elimination program
Insuring Peg –interferon for treating delta hepatitis( Now insured only for HCV).
Availability of Tenofovir for chronic HBV treatment ( Now available)
Insuring molecular lab tests for HBV( HBV DNA- HBV viral load) that last week has been insured

13. Hepatitis C
Completing insuring of new HCVtreatment drugs ( now some have been insured)
Molecular HCV tests has been insured last week HCV PCR, HCV Viral Load&و HCV Genotype
،Continuing harm reduction programs especially in FSWs and IDUs.